A common description of antibiotic action aims to classify them between “bactericidal” or “bacteriostatic”. Although these phenomena have robust in vitro foundations, the clinical translation of these concepts is sometimes difficult to ascertain. This controversial topic has important conceptual ramifications to treat severe infections. Today, we will discuss this topic with an expert in field.
Topics discussed:
- The definitions of “cidal” vs “static” antibiotics
- The clinical applicability of the above terms in terms of antibiotic choice and syndromatic approaches
- antibiotic choices and the controversy between bactericidal and bacteriostatic antibiotics.
Guest:
- Brad Spellberg, MD., Chief Medical Officer at the Los Angeles General Medical Center
Links:
- 黑料正能量and IDSA launch the (IMARI) in 2026
This episode is brought to you by the .
Visit to browse issues and/or submit a manuscript. If you plan to publish in AAC, 黑料正能量Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
Subscribe to Editors in Conversation (free) on , , .